360 related articles for article (PubMed ID: 33070186)
1. Supplementation of Bovine Colostrum in Inflammatory Bowel Disease: Benefits and Contraindications.
Sienkiewicz M; Szymańska P; Fichna J
Adv Nutr; 2021 Mar; 12(2):533-545. PubMed ID: 33070186
[TBL] [Abstract][Full Text] [Related]
2. Potential benefits of colostrum in gastrointestinal diseases.
Menchetti L; Traina G; Tomasello G; Casagrande-Proietti P; Leonardi L; Barbato O; Brecchia G
Front Biosci (Schol Ed); 2016 Jun; 8(2):331-51. PubMed ID: 27100711
[TBL] [Abstract][Full Text] [Related]
3. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases.
Sobczak M; Fabisiak A; Murawska N; Wesołowska E; Wierzbicka P; Wlazłowski M; Wójcikowska M; Zatorski H; Zwolińska M; Fichna J
Pharmacol Rep; 2014 Oct; 66(5):766-75. PubMed ID: 25149979
[TBL] [Abstract][Full Text] [Related]
4. Potential role of nutraceutical compounds in inflammatory bowel disease.
Larussa T; Imeneo M; Luzza F
World J Gastroenterol; 2017 Apr; 23(14):2483-2492. PubMed ID: 28465632
[TBL] [Abstract][Full Text] [Related]
5. Colostrum Therapy for Human Gastrointestinal Health and Disease.
Chandwe K; Kelly P
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34200282
[TBL] [Abstract][Full Text] [Related]
6. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
[TBL] [Abstract][Full Text] [Related]
7. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease.
Ghattamaneni NKR; Panchal SK; Brown L
Pharmacol Res; 2018 Jun; 132():99-107. PubMed ID: 29680446
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease: etiology, pathogenesis and current therapy.
Ko JK; Auyeung KK
Curr Pharm Des; 2014; 20(7):1082-96. PubMed ID: 23782147
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Applications of Human and Bovine Colostrum in the Treatment of Gastrointestinal Diseases and Distinctive Cancer Types: The Current Evidence.
Bagwe-Parab S; Yadav P; Kaur G; Tuli HS; Buttar HS
Front Pharmacol; 2020; 11():01100. PubMed ID: 33071773
[TBL] [Abstract][Full Text] [Related]
10. Current therapy of inflammatory bowel disease in children.
Rufo PA; Bousvaros A
Paediatr Drugs; 2006; 8(5):279-302. PubMed ID: 17037946
[TBL] [Abstract][Full Text] [Related]
11. Therapy of inflammatory bowel diseases in pregnancy and lactation.
Cassina M; Fabris L; Okolicsanyi L; Gervasi MT; Memmo A; Tiboni GM; Di Gianantonio E; Clementi M
Expert Opin Drug Saf; 2009 Nov; 8(6):695-707. PubMed ID: 19832551
[TBL] [Abstract][Full Text] [Related]
12. Exercise and exposure to heat following bovine colostrum supplementation: a review of gastrointestinal and immune function.
Carrillo AE; Koutedakis Y; Flouris AD
Cell Mol Biol (Noisy-le-grand); 2013 Nov; 59(1):84-8. PubMed ID: 24200023
[TBL] [Abstract][Full Text] [Related]
13. Bovine colostrum: an emerging nutraceutical.
Bagwe S; Tharappel LJ; Kaur G; Buttar HS
J Complement Integr Med; 2015 Sep; 12(3):175-85. PubMed ID: 25781716
[TBL] [Abstract][Full Text] [Related]
14. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
15. Insights into the Research Trends on Bovine Colostrum: Beneficial Health Perspectives with Special Reference to Manufacturing of Functional Foods and Feed Supplements.
Mehra R; Garhwal R; Sangwan K; Guiné RPF; Lemos ET; Buttar HS; Visen PKS; Kumar N; Bhardwaj A; Kumar H
Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277018
[TBL] [Abstract][Full Text] [Related]
16. Conventional drug therapy for inflammatory bowel disease.
Bryant RV; Brain O; Travis SP
Scand J Gastroenterol; 2015 Jan; 50(1):90-112. PubMed ID: 25523560
[TBL] [Abstract][Full Text] [Related]
17. Bovine colostrum supplementation and exercise performance: potential mechanisms.
Shing CM; Hunter DC; Stevenson LM
Sports Med; 2009; 39(12):1033-54. PubMed ID: 19902984
[TBL] [Abstract][Full Text] [Related]
18. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders.
Playford RJ; Macdonald CE; Johnson WS
Am J Clin Nutr; 2000 Jul; 72(1):5-14. PubMed ID: 10871554
[TBL] [Abstract][Full Text] [Related]
19. Bovine Colostrum Treatment of Specific Cancer Types: Current Evidence and Future Opportunities.
Alsayed AR; Hasoun LZ; Khader HA; Basheti IA; Permana AD
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557775
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic implications of functional tea ingredients for ameliorating inflammatory bowel disease: a focused review.
Huang Y; Xing K; Qiu L; Wu Q; Wei H
Crit Rev Food Sci Nutr; 2022; 62(19):5307-5321. PubMed ID: 33635174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
